Welcome to Dividend.com
Please help us personalize your experience.
Select the one that best describes you

T. Rowe Price Health Sciences Fund

mutual fund
PRHSX
Dividend policy
Active
Price as of:
$101.47 +0.05 +0%
primary theme
Health Care Sector Equity
share class
PRHSX (Mutual Fund)

T. Rowe Price Health Sciences Fund

Dividend policy
Active
Price as of:
$101.47 +0.05 +0%
primary theme
Health Care Sector Equity
share class
PRHSX (Mutual Fund)
T. Rowe Price Health Sciences Fund
Dividend policy
Active
Price as of:
$101.47 +0.05 +0%
primary theme
Health Care Sector Equity
share class

PRHSX - Snapshot

Vitals

  • YTD Return 24.6%
  • 3 Yr Annualized Return 17.4%
  • 5 Yr Annualized Return 13.7%
  • Net Assets $16.7 B
  • Holdings in Top 10 34.0%

52 WEEK LOW AND HIGH

$101.42
$60.38
$101.47

Expenses

OPERATING RELATED FEES

  • Expense Ratio 0.76%

SALES FEES

  • Front Load N/A
  • Deferred Load N/A

BROKERAGE FEES

  • Turnover 38.80%

TRADING FEES

  • Max Redemption Fee N/A

Min Investment

  • Standard (Taxable) $2,500
  • IRA $1,000

Fund Classification

  • Primary Theme Health Care Sector Equity
  • Fund Type Open End Mutual Fund
  • Investment Style Health

Compare PRHSX to Popular Health Care Sector Equity Funds

Overview

Next Dividend

Income Profile

Income Risk

Returns Profile

Allocations

Expenses

About

Dividend.com Ratings*

$109.21

+0.57%

$14.12 B

1.17%

$1.27

blocked
blocked
blocked

13.82%

-

Compare PRHSX to Popular Health Care Sector Equity ETFs

Overview

Next Dividend

Income Profile

Income Risk

Returns Profile

Allocations

Expenses

About

Dividend.com Ratings*

$111.49

+0.75%

$24.57 B

1.49%

$1.65

blocked
blocked
blocked

9.32%

-

$218.28

+0.49%

$14.12 B

1.17%

$2.55

blocked
blocked
blocked

13.84%

-

$144.99

-0.23%

$9.78 B

0.21%

$0.30

blocked
blocked
blocked

21.52%

-

$315.37

+0.50%

$8.75 B

0.27%

$0.84

blocked
blocked
blocked

19.03%

-

$132.82

-0.09%

$6.82 B

0.08%

$0.11

blocked
blocked
blocked

40.60%

-

PRHSX - Profile

Distributions

  • YTD Total Return 24.6%
  • 3 Yr Annualized Total Return 17.4%
  • 5 Yr Annualized Total Return 13.7%
  • Capital Gain Distribution Frequency Annually
  • Net Income Ratio 0.00%
DIVIDENDS
  • Dividend Yield 0.0%
  • Dividend Distribution Frequency Annually

Fund Details

  • Legal Name
    T. Rowe Price Health Sciences Fund
  • Fund Family Name
    T. Rowe Price
  • Inception Date
    Dec 29, 1995
  • Shares Outstanding
    N/A
  • Share Class
    No Load
  • Currency
    USD
  • Domiciled Country
    United States
  • Manager
    Ziad Bakri

Fund Description

The fund will normally invest at least 80% of its net assets (including any borrowings for investment purposes) in the common stocks of companies engaged in the research, development, production, or distribution of products or services related to health care, medicine, or the life sciences (collectively termed "health sciences"). While the fund can invest in companies of any size, the majority of fund assets are expected to be invested in large- and mid-capitalization companies. It is non-diversified.


PRHSX - Performance

Return Ranking - Trailing

Period PRHSX Return Category Return Low Category Return High Rank in Category (%)
YTD 24.6% -3.6% 157.0% 22.36%
1 Yr 27.9% 1.8% 148.1% 28.83%
3 Yr 17.4%* 2.7% 51.8% 12.59%
5 Yr 13.7%* -0.5% 34.2% 13.57%
10 Yr 20.8%* 9.6% 21.4% 3.25%

* Annualized

Return Ranking - Calendar

Period PRHSX Return Category Return Low Category Return High Rank in Category (%)
2019 21.5% 3.8% 63.8% 42.07%
2018 -4.7% -49.7% 21.5% 37.96%
2017 19.1% -59.8% 54.4% 49.63%
2016 -14.2% -36.6% 11.6% 49.61%
2015 1.3% -62.4% 27.9% 33.61%

Total Return Ranking - Trailing

Period PRHSX Return Category Return Low Category Return High Rank in Category (%)
YTD 24.6% -3.6% 147.2% 22.36%
1 Yr 27.9% -3.5% 148.1% 25.15%
3 Yr 17.4%* 1.8% 51.8% 12.59%
5 Yr 13.7%* -0.5% 34.2% 13.57%
10 Yr 20.8%* 9.5% 21.4% 3.25%

* Annualized

Total Return Ranking - Calendar

Period PRHSX Return Category Return Low Category Return High Rank in Category (%)
2019 21.5% 3.8% 63.8% 42.07%
2018 -4.7% -25.3% 22.2% 45.26%
2017 19.1% -10.8% 54.4% 60.74%
2016 -14.2% -36.6% 11.6% 58.91%
2015 1.3% -16.6% 27.9% 66.39%

NAV & Total Return History


PRHSX - Holdings

Concentration Analysis

PRHSX Category Low Category High PRHSX % Rank
Net Assets 16.7 B 4.64 M 46 B 2.91%
Number of Holdings 154 24 426 10.47%
Net Assets in Top 10 4.84 B 1.01 M 19.6 B 4.65%
Weighting of Top 10 33.98% 15.4% 77.0% 75.58%

Top 10 Holdings

  1. UnitedHealth Group Inc 6.10%
  2. Thermo Fisher Scientific Inc 4.43%
  3. Intuitive Surgical Inc 4.24%
  4. Intuitive Surgical Inc 4.24%
  5. Intuitive Surgical Inc 4.24%
  6. Intuitive Surgical Inc 4.24%
  7. Intuitive Surgical Inc 4.24%
  8. Intuitive Surgical Inc 4.24%
  9. Intuitive Surgical Inc 4.24%
  10. Intuitive Surgical Inc 4.24%

Asset Allocation

Weighting Return Low Return High PRHSX % Rank
Stocks
99.26% 76.86% 100.05% 41.28%
Other
0.60% -1.51% 10.43% 23.84%
Preferred Stocks
0.14% 0.00% 4.75% 12.79%
Convertible Bonds
0.00% 0.00% 0.05% 65.70%
Cash
0.00% -0.28% 12.53% 88.37%
Bonds
0.00% 0.00% 16.11% 66.28%

Stock Sector Breakdown

Weighting Return Low Return High PRHSX % Rank
Healthcare
99.41% 61.64% 100.00% 54.07%
Basic Materials
0.53% 0.00% 3.14% 20.35%
Financial Services
0.05% 0.00% 3.21% 30.23%
Utilities
0.00% 0.00% 0.00% 64.53%
Technology
0.00% 0.00% 15.86% 70.93%
Real Estate
0.00% 0.00% 6.03% 68.02%
Industrials
0.00% 0.00% 5.94% 68.60%
Energy
0.00% 0.00% 0.00% 64.53%
Communication Services
0.00% 0.00% 4.69% 66.86%
Consumer Defense
0.00% 0.00% 33.59% 68.02%
Consumer Cyclical
0.00% 0.00% 1.21% 68.02%

Stock Geographic Breakdown

Weighting Return Low Return High PRHSX % Rank
US
86.89% 56.70% 99.99% 27.33%
Non US
12.37% 0.00% 43.24% 58.14%

PRHSX - Expenses

Operational Fees

PRHSX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Expense Ratio 0.76% 0.08% 25.14% 70.48%
Management Fee 0.64% 0.00% 1.25% 51.16%
12b-1 Fee N/A 0.00% 1.00% 4.17%
Administrative Fee 0.15% 0.03% 0.40% 75.00%

Sales Fees

PRHSX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Front Load N/A 3.50% 5.75% N/A
Deferred Load N/A 1.00% 5.00% N/A

Trading Fees

PRHSX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Max Redemption Fee N/A 1.00% 2.00% N/A

Related Fees

Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.

PRHSX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Turnover 38.80% 0.70% 252.00% 53.37%

PRHSX - Distributions

Dividend Yield Analysis

PRHSX Category Low Category High PRHSX % Rank
Dividend Yield 0.00% 0.00% 3.15% 72.67%

Dividend Distribution Analysis

PRHSX Category Low Category High Category Mod
Dividend Distribution Frequency Annually Annually Semi-Annually Annually

Net Income Ratio Analysis

PRHSX Category Low Category High PRHSX % Rank
Net Income Ratio 0.00% -2.53% 2.53% 49.70%

Capital Gain Distribution Analysis

PRHSX Category Low Category High Capital Mode
Capital Gain Distribution Frequency Annually Annually Semi-Annually Annually

Dividend Payout History

View More +

PRHSX - Fund Manager Analysis

Managers

Ziad Bakri


Start Date

Tenure

Tenure Rank

Apr 01, 2016

4.67

4.7%

Ziad Bakri joined T. Rowe Price in 2011 and has since been a key member of the healthcare research team, influencing investment decisions and making significant contributions to the stock selections. Ziad has had a long track record of analyzing biotechnology companies, a key sector within the healthcare industry. Ziad brings a unique perspective to his new role, having been a medical doctor and an emergency medicine resident at the Royal London Hospital before beginning his investment career. Prior to joining T. Rowe Price, Ziad held biotechnology equity research and healthcare investment banking analyst positions in other investment firms

Tenure Analysis

Category Low Category High Category Average Category Mode
0.17 23.22 7.36 20.6

Continue to site >
Trending ETFs